Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0079 | 0.1644 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0134 | 0.3187 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0046 | 0.0737 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0046 | 0.0737 | 0.2314 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0079 | 0.1644 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0134 | 0.3187 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0055 | 0.0987 | 0.3096 |
Onchocerca volvulus | 0.0055 | 0.0987 | 0.5 | |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0032 | 0.0352 | 0.4775 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.1644 | 0.5157 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 0 | 0.5 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0079 | 0.1644 | 0.5157 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0051 | 0.0885 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3187 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0377 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0134 | 0.3187 | 0.3187 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 0 | 0.5 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0079 | 0.1644 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0134 | 0.3187 | 0.3187 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0032 | 0.0352 | 0.1053 |
Brugia malayi | Probable ClpP-like protease | 0.0079 | 0.1644 | 0.5157 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.002 | 0 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0046 | 0.0737 | 1 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 0.5 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 0.5 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.3015 | 0.9461 |
Echinococcus multilocularis | dna polymerase eta | 0.0046 | 0.0737 | 0.0737 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0051 | 0.0885 | 0.0885 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3187 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.3015 | 0.9461 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3187 | 1 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 0.1644 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0051 | 0.0885 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0079 | 0.1644 | 1 |
Brugia malayi | TAR-binding protein | 0.0134 | 0.3187 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0046 | 0.0737 | 0.0737 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0051 | 0.0885 | 0.0885 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0134 | 0.3187 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0134 | 0.3187 | 1 |
Brugia malayi | RNA binding protein | 0.0134 | 0.3187 | 1 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3187 | 1 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 0.1644 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0079 | 0.1644 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0737 | 0.2314 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0987 | 0.3096 |
Schistosoma mansoni | DNA polymerase eta | 0.0046 | 0.0737 | 0.2314 |
Leishmania major | DNA polymerase eta, putative | 0.0032 | 0.0352 | 0.4775 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0051 | 0.0885 | 0.4744 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3187 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0046 | 0.0737 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.3015 | 0.9461 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 246 % | Activity at GABAA alpha-5-beta-3-gamma-2 receptor expressed in oocytes assessed as stimulation of GABA-induced current at 1 uM relative to control | ChEMBL. | 19275170 |
Activity (binding) | = 248 % | Activity at GABAA alpha-1-beta-3-gamma-2 receptor expressed in oocytes assessed as stimulation of GABA-induced current at 1 uM relative to control | ChEMBL. | 19275170 |
Activity (binding) | = 410 % | Activity at GABAA alpha-2-beta-3-gamma-2 receptor expressed in oocytes assessed as stimulation of GABA-induced current at 1 uM relative to control | ChEMBL. | 19275170 |
Activity (binding) | = 596 % | Activity at GABAA alpha-3-beta-3-gamma-2 receptor expressed in oocytes assessed as stimulation of GABA-induced current at 1 uM relative to control | ChEMBL. | 19275170 |
ED50 (functional) | = 8.87 mg kg-1 | Anticonvulsant activity in ip dosed mouse assessed as protection against subcutaneous metrazole-induced seizure | ChEMBL. | 19275170 |
ED50 (functional) | > 200 mg kg-1 | Anticonvulsant activity in ip dosed mouse assessed as protection against maximal electroshock-induced seizure | ChEMBL. | 19275170 |
TD50 (ADMET) | > 400 mg kg-1 | Toxicity in ip dosed mouse assessed as minimal muscular or neurological impairment by rotarod paradigm test | ChEMBL. | 19275170 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.